Shandong Xinhua Pharmaceutical (000756.SZ) stated on the investor interaction platform on July 15th that the company has continued to increase its research and development investment in recent years, with a research and development investment of 0.406 billion yuan in 2023 and over 100 innovative drugs and generics in the R&D pipeline.
新华制药(000756.SZ)：2023年研发投入达4.06亿元
Shandong Xinhua Pharmaceutical (000756.SZ): research and development investment in 2023 reached 0.406 billion yuan.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.